drugset
Drugs / High Dose Trivalent Influenza Vaccine
last change Jan 2021 re-read 2 minutes ago

High Dose Trivalent Influenza Vaccine

Vaccine

Investigated by
Boston VA Research Institute, Inc. · Brigham and Women's Hospital · National Heart, Lung, and Blood Institute (NHLBI) · Patient-Centered Outcomes Research Institute · University of Minnesota · University of Toronto
+1 more · University of Wisconsin, Madison

Trials 1 · a red edge is where a trial was stopped

today NCT02787044 · Ph 4
2017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02787044 Aug 2016 → May 2020 heart failure, myocardial infarction Brigham and Women's Hospital Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as High Dose Trivalent Influenza Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02787044 ↗
Modality Vaccine “high-dose trivalent inactivated influenza vaccine” PMID 33275134 ↗ Jan 2021